Who owns LIPOCINE INC NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Lipocine with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lipocine stock

Who bought or sold LIPOCINE INC NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 222k $635k -1% Sep 2025
 View chart
BlackRock 89k $254k 0% Sep 2025
 View chart
Geode Capital Management 61k $175k 0% Sep 2025
 View chart
Susquehanna International 47k $134k 2% Sep 2025
 View chart
Renaissance Technologies 36k $103k 4% Sep 2025
 View chart
State Street Corporation 19k $53k 0% Sep 2025
 View chart
Citadel Advisors 14k $41k 100% Sep 2025
 View chart
Northern Trust 13k $38k 0% Sep 2025
 View chart
Dimensional Fund Advisors 12k $35k -49% Sep 2025
 View chart
Barclays 9.4k $27k 0% Sep 2025
 View chart
Advisor Group Holdings 2.3k $6.5k -1% Sep 2025
 View chart
UBS Group 1.8k $5.3k 272% Sep 2025
 View chart
Tower Research Capital 1.2k $3.3k 74% Sep 2025
 View chart
Morgan Stanley 575.00 $1.7k 100% Jun 2025
 View chart
Caldwell Sutter Capital 471.00 $1.3k 0% Sep 2025
 View chart
Group One Trading 162.00 $462.996000 0% Sep 2025
 View chart
SBI Securities 67.00 $190.996900 0% Sep 2025
 View chart
Tidemark 59.00 $168.002500 0% Sep 2025
 View chart
FMR 59.00 $168.999600 100% Sep 2025
 View chart
Royal Bank of Canada 1.00 $0 100% Sep 2025
 View chart

Who sold out of Lipocine?

Fund or Company Name Date Sold Shares Held Valued At
Jpmorgan Chase & Co Mar 2025 11.00 $34.999800